Monoclonal antihuman thyroglobulin antibodies

Area of Science:

• Immunology
• Endocrinology
• Biochemistry

Background:

• Monoclonal antibodies are crucial tools in biomedical research.
• Thyroglobulin (Tg) is a key protein in thyroid hormone synthesis and a potential biomarker for thyroid diseases.
• Characterizing antibodies against Tg is essential for understanding thyroid function and pathology.

Purpose of the Study:

• To establish and characterize monoclonal antibodies specific to human thyroglobulin (Tg).
• To investigate the binding specificities and epitope recognition of these antibodies.
• To explore the utility of these antibodies as probes for human Tg polymorphism.

Main Methods:

• Hybridoma technology was used to generate six monoclonal antibodies (TAK 1-6) against human Tg.
• Solid-phase radioimmunoassay (RIA) detected antibody presence in hybridoma supernatants.
• Radioimmune blocking assays and competitive inhibition studies analyzed antibody characteristics, including specificity, cross-reactivity, and epitope recognition.

Main Results:

• Two antibodies (TAK 2 and 3) showed specific binding to human Tg, recognizing unmodified structures.
• Four antibodies (TAK 1, 4, 5, and 6) cross-reacted with rat Tg, with affinity increasing with human Tg iodination.
• Antibody binding was differentially inhibited by T4 and other thyroid hormones, defining distinct epitope groups.

Conclusions:

• Six distinct monoclonal antihuman Tg antibodies were successfully generated.
• These antibodies recognize different epitopes on Tg, including framework structures, iodination-related sites, and T4-containing determinants.
• The developed monoclonal antibodies serve as valuable tools for investigating human Tg heterogeneity and its implications in thyroid disease.